The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124599522 12459952 2 F 2015 20160726 20160613 20160729 EXP US-JNJFOC-20160604262 JANSSEN 0.00 A F Y 61.24000 KG 20160729 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124599522 12459952 1 SS FENTANYL TRANSDERMAL SYSTEM FENTANYL 1 Transdermal LATE FALL OR DEC-2015 N 1405366P1;UNKNOWN 0 MATRIX PATCH
124599522 12459952 2 PS FENTANYL TRANSDERMAL SYSTEM FENTANYL 1 Transdermal LATE FALL OR DEC-2015 N 1405366P1;UNKNOWN 19813 MATRIX PATCH
124599522 12459952 3 C GABAPENTIN. GABAPENTIN 1 Oral 0 300 MG CAPSULE TID
124599522 12459952 4 C FLEXERIL CYCLOBENZAPRINE HYDROCHLORIDE 1 Oral 0 10 MG TABLET TID
124599522 12459952 5 C KEPPRA LEVETIRACETAM 1 Oral 0 250 MG TABLET BID
124599522 12459952 6 C PREVACID LANSOPRAZOLE 1 Oral 0 30 MG CAPSULES BID
124599522 12459952 7 C TOPROL XL METOPROLOL SUCCINATE 1 Oral 0 25 MG TABLET BID
124599522 12459952 8 C MORPHINE MORPHINE 1 Unknown 0 30 MG TABLET
124599522 12459952 9 C ZANTAC RANITIDINE HYDROCHLORIDE 1 Oral 0 150 MG TABLET
124599522 12459952 10 C SEREVENT DISKUS SALMETEROL XINAFOATE 1 Oral 0 1 DF INHALATION
124599522 12459952 11 C FLOVENT FLUTICASONE PROPIONATE 1 Oral 0 1 DF INHALATION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124599522 12459952 1 Cancer pain
124599522 12459952 2 Neuralgia
124599522 12459952 3 Neuralgia
124599522 12459952 4 Muscle spasms
124599522 12459952 5 Muscle spasms
124599522 12459952 6 Gastrooesophageal reflux disease
124599522 12459952 7 Arrhythmia prophylaxis
124599522 12459952 8 Pain
124599522 12459952 9 Gastrooesophageal reflux disease
124599522 12459952 10 Asthma
124599522 12459952 11 Asthma

Outcome of event

Event ID CASEID OUTC COD
124599522 12459952 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124599522 12459952 Gastrointestinal stoma complication
124599522 12459952 Off label use
124599522 12459952 Product adhesion issue
124599522 12459952 Wrong technique in product usage process

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124599522 12459952 1 201512 0
124599522 12459952 2 201512 0
124599522 12459952 3 2009 0
124599522 12459952 4 2009 0
124599522 12459952 5 201603 0
124599522 12459952 7 1990 0
124599522 12459952 8 2008 0